Skip to main content
Clinical Trials/NCT03924362
NCT03924362UnknownNot Applicable

A Prospective Trial of Feasibility and Efficacy of Simultaneous Bilateral Percutaneous Nephrolithotomy

University of British Columbia2 sites in 1 country92 target enrollmentStarted: September 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
92
Locations
2
Primary Endpoint
Stone Free Rates Measured using Chi-Square analysis.

Study Overview

Brief Summary

The purpose of this study is to determine the effective regimen for definitive surgical therapy of bilateral kidney stones. It is unknown whether patients who undergo simultaneous bilateral percutaneous nephrolithotomy (PCNL) experience improved post-operative outcomes compared to patients who have staged unilateral procedures.

Detailed Description

Purpose:

The aim of this research is to determine an effective regimen for definitive surgical therapy of bilateral kidney stones. It is unknown whether patients who undergo simultaneous bilateral percutaneous nephrolithotomy (PCNL) experience improved post-operative outcomes compared to patients who have staged unilateral procedures.

Hypothesis and Justification The gold standard for surgical management of large kidney stones is percutaneous nephrolithotomy (PCNL). A large renal stone burden has been defined as >20mm. In addition, PCNL has improved stone-free rates for lower pole calculi >10mm compared to alternative treatments. Guidelines encourage removal of staghorn calculi for surgical candidates (Assimos et al., 2016). Patients with bilateral large stone burdens have been managed with one of two general options: (i) a single procedure in which both kidneys are operated upon or (ii) two separate procedures in which only one kidney is addressed per procedure. However, there are no prospectively performed peer-reviewed studies directly comparing the two practices. The investigators seek to determine whether there is a significant difference in patient outcomes based on the surgical regimen chosen.

The investigators hypothesize that in comparison to unilateral PCNL (U-PCNL), simultaneous bilateral PCNL (SB-PCNL) under one anesthetic results in comparable

  1. stone free rates
  2. re-intervention rates for residual stones and
  3. perioperative complication rates

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • All subjects with a clinical diagnosis of struvite calculi will potentially be included. Specific inclusion criteria include the following:
  • Age >18 years
  • Any patient with bilateral stone burden eligible and appropriate for PCNL procedure
  • Medically fit for definitive surgical management of stone.

Exclusion Criteria

  • Patients with any of the following characteristics will not be eligible for the present study:
  • Those with medical comorbidities preventing them from safely undergoing definitive surgical therapy.
  • Patients who are unable to provide informed consent.
  • Patients who are planned for alternative procedures (ureteroscopy, extracorporeal shock wave lithotripsy)
  • Anyone who is unable to give their informed consent
  • Anyone under the age of 19
  • Anyone who, in the opinion of the PI, is unfit or unsuitable to participate in the study

Outcomes

Primary Outcomes

Stone Free Rates Measured using Chi-Square analysis.

Time Frame: 3 months.

Rate of clearance of kidney stones following the procedure.

Number of Participants with Repeat procedures

Time Frame: 3 months.

Number of Participants requiring repeat surgical procedures for residual stones following initial treatment.

Secondary Outcomes

  • Patient Quality of Life(3 months.)
  • Length of hospital stay(3 months.)
  • Number of Participants with Complications(3 months.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ben Chew, MD

Associate Professor

University of British Columbia

Study Sites (2)

Loading locations...

Similar Trials